Register entry

SciAnda (Changshu) Pharmaceuticals, Ltd.

Registered sites
1
Drug products
16
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufactureFinished drug manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
SciAnda (Changshu) Pharmaceuticals, Ltd.ChangshuChinaActive ingredient (API) manufacture, Finished drug manufacture3009853264
Catalogue

Marketed products

16

Showing 16 of 16.

BrandGeneric nameFormCategory
-AbemaciclibPOWDERBULK INGREDIENT
-AlpelisibPOWDERBULK INGREDIENT
-Atazanavir SulfatePOWDERBULK INGREDIENT
-BimatoprostPOWDERBULK INGREDIENT
-BortezomibPOWDERBULK INGREDIENT
-CapecitabinePOWDERBULK INGREDIENT
-CelecoxibPOWDERBULK INGREDIENT
-DecitabinePOWDERBULK INGREDIENT
-Eflornithine HydrochloridePOWDERBULK INGREDIENT
-GefitinibPOWDERBULK INGREDIENT
-Gemcitabine HydrochloridePOWDERBULK INGREDIENT
-Lapatinib DitosylatePOWDERBULK INGREDIENT
-OlaparibPOWDERBULK INGREDIENT
-Osimertinib MesylatePOWDERBULK INGREDIENT
-RoflumilastPOWDERBULK INGREDIENT
-TOPIRAMATEPOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.